Skip to main content
. 2017 Apr 20;12(4):e0175850. doi: 10.1371/journal.pone.0175850

Fig 5. Power of prognosis markers.

Fig 5

(A) Kaplan-Meier plots of high-risk and low-risk patients grouped by prognosis markers on validate dataset GSE8894. (B) Prognosis risk scores in all RNA-seq and microarray datasets. (C) ROC curves for tumor-normal discrimination by selected markers in all RNA-seq and microarray datasets.